BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 3104049)

  • 1. Evaluation of low dose anaphylatoxic peptides in the pathogenesis of the adult respiratory distress syndrome (ARDS). Monitoring of early C5a effects in a guinea-pig in vivo model after i.v. application.
    Hoffmann T; Böttger EC; Baum HP; Dennebaum R; Hadding U; Bitter-Suermann D
    Eur J Clin Invest; 1986 Dec; 16(6):500-8. PubMed ID: 3104049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complement activation and clearance in acute illness and injury: evidence for C5a as a cell-directed mediator of the adult respiratory distress syndrome in man.
    Solomkin JS; Cotta LA; Satoh PS; Hurst JM; Nelson RD
    Surgery; 1985 Jun; 97(6):668-78. PubMed ID: 4002115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant human C5a-induced bronchoconstriction in the guinea pig: inhibition by an H1 antagonist after depletion of circulating granulocytes and platelets.
    Fraser DG; Regal JF
    J Pharmacol Exp Ther; 1991 Dec; 259(3):1213-20. PubMed ID: 1684819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. C5a-induced bronchoconstriction: absence of a role of circulating white blood cells and platelets.
    Regal JF
    Int Arch Allergy Appl Immunol; 1988; 86(2):196-200. PubMed ID: 3391686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of C3a in pulmonary alveoli following trauma.
    Obertacke U; Joka T; Zilow G; Kirschfink M; Schmit-Neuerburg KP
    Prog Clin Biol Res; 1989; 308():43-9. PubMed ID: 2789395
    [No Abstract]   [Full Text] [Related]  

  • 6. Association of complement activation and elevated plasma-C5a with adult respiratory distress syndrome. Pathophysiological relevance and possible prognostic value.
    Hammerschmidt DE; Weaver LJ; Hudson LD; Craddock PR; Jacob HS
    Lancet; 1980 May; 1(8175):947-9. PubMed ID: 6103300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of C5 in septic lung injury.
    Olson LM; Moss GS; Baukus O; Das Gupta TK
    Ann Surg; 1985 Dec; 202(6):771-6. PubMed ID: 4073989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complement, granulocytes, and shock lung.
    Craddock PR
    Am J Emerg Med; 1984 Jan; 2(1):78-81. PubMed ID: 6517988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complement-induced granulocyte aggregation. Importance in myocardial infarction and shock lung.
    Jacob HS; Hammerschmidt DE
    JAMA; 1981 May 22-29; 245(20):2013-7. PubMed ID: 7230395
    [No Abstract]   [Full Text] [Related]  

  • 10. Complement activation and adult respiratory distress syndrome during intermittent flow apheresis procedures.
    Boogaerts MA; Roelant C; Goossens W; Verwilghen RL
    Transfusion; 1986; 26(1):82-7. PubMed ID: 3946010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Validity of the granulocyte aggregation test for the evaluation of complement activation in the adult respiratory distress syndrome].
    Ortolani O; Conti A; Minale F; Imperatore R; Mazzarella L
    Boll Soc Ital Biol Sper; 1985 Aug; 61(8):1207-14. PubMed ID: 4063110
    [No Abstract]   [Full Text] [Related]  

  • 12. Induction of platelet aggregation by the complement-derived peptides C3a and C5a.
    Grossklaus C; Damerau B; Lemgo E; Vogt W
    Naunyn Schmiedebergs Arch Pharmacol; 1976 Oct; 295(1):71-6. PubMed ID: 1004644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo effects of C3a on neutrophils and its contribution to inflammatory lung processes in a guinea-pig model.
    Hoffmann T; Böttger EC; Baum HP; Messner M; Hadding U; Bitter-Suermann D
    Clin Exp Immunol; 1988 Mar; 71(3):486-92. PubMed ID: 3260158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. On the pathogenesis of adult respiratory distress syndrome--the role of anaphylatoxins, leukotrienes and platelet activating factor.
    Pison U; Schmit-Neuerburg KP; König W
    Prog Clin Biol Res; 1987; 236A():317-26. PubMed ID: 2441409
    [No Abstract]   [Full Text] [Related]  

  • 15. Pulmonary injury induced by C3a and C5a anaphylatoxins.
    Stimler NP; Hugli TE; Bloor CM
    Am J Pathol; 1980 Aug; 100(2):327-48. PubMed ID: 6967702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of anti-C5a antibodies on the adult respiratory distress syndrome in septic primates.
    Stevens JH; O'Hanley P; Shapiro JM; Mihm FG; Satoh PS; Collins JA; Raffin TA
    J Clin Invest; 1986 Jun; 77(6):1812-6. PubMed ID: 3711336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. C5a-induced histamine release. Species specificity.
    Regal JF; Hardy TM; Casey FB; Chakrin LW
    Int Arch Allergy Appl Immunol; 1983; 72(4):362-5. PubMed ID: 6196303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complement and the severity of pulmonary failure.
    Weigelt JA; Chenoweth DE; Borman KR; Norcross JF
    J Trauma; 1988 Jul; 28(7):1013-9. PubMed ID: 3260964
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High dose corticosteroids and cell-cell interactions.
    Kjellström BT; Risberg B
    Acta Chir Scand Suppl; 1985; 526():37-47. PubMed ID: 3911707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. C5a-induced myocardial ischemia: role for CD18-dependent PMN localization and PMN-platelet interactions.
    Fletcher MP; Stahl GL; Longhurst JC
    Am J Physiol; 1993 Nov; 265(5 Pt 2):H1750-61. PubMed ID: 7902015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.